Skip to main content
. 2022 Aug 12;14(8):1676. doi: 10.3390/pharmaceutics14081676

Figure 1.

Figure 1

CONSORT diagram of the OPTIM-imatinib study. [C]min: trough imatinib plasma level, ELN: European Leukemia Net, AE: adverse event.